Biome Australia – Quarterly Activities & Appendix 4C March 2024

● Biome records first positive quarterly EBITDA (unaudited) in Q3 FY24
● Biome records first positive quarter of underlying operating cash flow in Q3
FY24
● Biome reports $3.2m sales revenue in Q3 FY24, up 74% vs. PCP
● Same-store sales in pharmacy increased 61.4% vs. PCP
● Overseas sales revenue for Q3 total $242k, led by early growth in the UK
health retail market
● Cash receipts totalled $3.05m in Q3 FY24
● Accounts receivable increased to $2.44m at the close of Q3 FY24, up from
$2.28m
● Biome finished the quarter with $2.1m cash at bank, an increase of $72k on
Q2 FY24